Results 241 to 250 of about 236,761 (380)
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad+9 more
wiley +1 more source
A Comparison of Different Guidelines for the Treatment of Acute Heart Failure and Their Extensibility to Emergency Departments: A Critical Reappraisal. [PDF]
Falsetti L+9 more
europepmc +1 more source
Impact of aldosterone deficiency on the development of diuretic resistance in mice. [PDF]
Essigke D+6 more
europepmc +1 more source
Diuretic Action of Ethacrynic Acid in Congestive Heart Failure [PDF]
D. J. Daley, Brian Evans
openalex +1 more source
Application of Metabolomics and the Discovery of Potential Serum Biomarkers for Diuretic Resistance in Heart Failure. [PDF]
Yu Y+7 more
europepmc +1 more source
Abstract Aims Electron microscopy reveals microstructural alterations in cardiomyocyte nuclei and myofilaments in non‐ischaemic cardiomyopathy (NICM), particularly in dilated cardiomyopathy (DCM). Nevertheless, the correlation between such observations and clinical outcomes, including prognosis and left ventricular reverse remodelling (LVRR), remains ...
Rie Higuchi+19 more
wiley +1 more source
Innovation in Diuretic Therapy
Stephen J. Greene, MD+1 more
doaj +1 more source
High-Complexity Questions and Their Answers for Everyday Heart Failure. [PDF]
Campos-Saénz de Santamaría A+12 more
europepmc +1 more source